Inogen Inc (NAS:INGN)
$ 8.61 -0.15 (-1.71%) Market Cap: 203.00 Mil Enterprise Value: 108.84 Mil PE Ratio: 0 PB Ratio: 1.06 GF Score: 67/100

Inogen Inc Strategy Update Call Transcript

Feb 27, 2023 / 03:00PM GMT
Release Date Price: $16.5 (+3.84%)
Operator

Hello, and welcome to Inogen's Strategy Update Conference Call. (Operator Instructions) As a reminder, this conference is being recorded today, February 27, 2023.

I would now like to turn the conference over to Nabil Shabshab, President and Chief Executive Officer. Please go ahead.

Nabil Shabshab
Inogen, Inc. - CEO, President & Director

Thank you, Kevin. Good morning, everyone, to people here in the room as well as people that have joined us on the webcast. My name again is Nabil Shabshab, I'm the President and the CEO of Inogen. I've been with the company for just about 2 years now. So before I start talking about the transformation, which is on Slide 3, I just want to maybe provide some context for people that as earlier with Inogen very briefly. So we're a global med tech company with a footprint in about 60 countries where we commercialize our products.

Our revenue in 2022 was $377 million. The more important thing is we operate in a very difficult disease state, COPD. According to the CDC, the U.S. prevalence of COPD in 2020 was

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot